Please add to your safe senders list.

The SITC Immune Monitor

Support SITC    Membership    Meetings    About SITC    

October 2015 – In this Issue

Members in the News | Education & Events | Publications| Careers

A Message from the President

Dear Colleagues,

For 30 years, SITC has continually delivered the latest, cutting-edge cancer immunotherapy information to scientists, practitioners, industry, government, patient advocates and patients alike. This year, more than ever before, cancer immunotherapy and the leading investigators in our field are at the forefront of the entire oncology field.

With a number of approaches demonstrating clinical benefit to patients in a variety of cancer types—and immunotherapy fast becoming a pillar of cancer care—it is no surprise that stakeholders across the globe have taken a keen interest in the promise of cancer immunotherapy. In response to this unprecedented growth and interest in the field, SITC has extended our 30th Anniversary Annual Meeting & Associated Programs to provide more opportunities for scientific exchange, networking and education than ever.

If you have not already done so, I encourage you to register for this momentous event, which will be held in National Harbor, Maryland from November 4 – 8, 2015. There, leaders from around the world will discuss and debate significant developments in tumor immunology, cancer immunotherapy, celebrate the history of the field, and articulate contemporary issues during sessions and programs designed with you in mind.

For more information and to register for SITC 2015 programming and special events, visit the SITC 2015 website.

I look forward to seeing you in person and continuing our work in this historic time.


Howard L. Kaufman, MD, FACS
SITC President

P.S. Early bird registration rates expire tomorrow, October 2 at 5 p.m. ET, so act fast!

Members in the News

Congratulations, James P. Allison, PhD!

We congratulate long-time SITC member, James P. Allison, PhD, on receiving the 2015 Lasker Award, the nation’s highest honor in clinical medical research. Dr. Allison's pioneering research on the regulation of T cells led to a new era in tumor immunotherapy. The development of drugs that block T cell checkpoints has revolutionized our approach to treating cancer and has brought hope to patients with all types of cancer who may now have a real chance at long-term survival.

Hear Dr. Allison discuss his journey in the field during the keynote Milestones in Immunotherapy session at SITC’s 30th Anniversary Annual Meeting on Friday, November 6! Learn more and register here.

Do you have news to share? Tell us about it!

Education & Events

State of SITC: Membership Business Meeting to be held at SITC 2015

Friday, November 6, 2015 • 7 – 7:45 a.m.
Gaylord National Hotel & Convention Center • National Harbor, Maryland

SITC invites all 30th Anniversary Annual Meeting attendees regardless of member status to join us for State of SITC: Membership Business Meeting. There, leaders will formally announce the election results and will present an update on current Society activities that are impacting the field, including an overview of major initiatives and collaborations, committee projects, and plans for the future.

Get more information and register for SITC 2015 here.

Tumor Immunology 101: A Navigation Guide for the Growing Field of Cancer Immunotherapy is Coming to a City Near You

Presented by leading authorities in tumor immunology and cancer immunotherapy, all Advances in Cancer ImmunotherapyTM series CME- and CNE-certified programs provide attendees with an understanding of cancer immunotherapies, their therapeutic effectiveness and the appropriate selection and management of patients.

Clinical oncologists, registered nurses, nurse practitioners and the entire medical team involved in treating cancer patients are encouraged to attend. Reserve your spot at one of the locations listed below!

The Advances in Cancer ImmunotherapyTM series is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the Society for Immunotherapy of Cancer in collaboration with Postgraduate Institute for Medicine.

Get more information, including registration and accreditation details, here.

Radiation and Immunity Meet the Clinic

Part of the American Society for Radiation Oncology (ASTRO) 2015 Annual Meeting

Wednesday, October 21, 2015 • 10:45 a.m. – 12:15 p.m.
Henry B. Gonzalez Convention Center • San Antonio, Texas

SITC is proud to partner with ASTRO on an innovative session on the current and evolving role of immunotherapy in cancer treatment.

Following a brief overview of immunotherapy for cancer—including the adverse event profiles of immunotherapies, their clinical management and response kinetics—the rationale for combining immunotherapy with radiation therapy will be explored through discussion of radiotherapy-immunotherapy combination studies in different disease states. Learn more.

Publications & Resources

Journal for ImmunoTherapy of Cancer, the Resource for Cutting-Edge Science in the Field

Journal for ImmunoTherapy of Cancer (JITC) is SITC's official open access, peer-reviewed journal. It encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research to clinical application. As the global voice of the Society, JITC is the resource for SITC publications. SITC’s 30th Anniversary Annual Meeting abstract supplement will be released on November 4, 2015, and meeting summaries and output papers will be published throughout 2016.

Additionally, JITC features monthly technology primers produced by the SITC Immune Biomarkers Task Force. A hot topic in the field, these papers examine the latest in biomarker technologies for cancer immunotherapy. Access the articles here, and consider joining us on November 8 for a biomarkers debate, Biomarkers in Cancer Immunotherapy: Oasis or Mirage?, part of SITC's 30th Anniversary Annual Meeting & Associated Programs.

Interested in publishing in JITC? SITC members receive waived article processing charges for papers accepted in 2015. Submit your manuscript here.

Stay tuned for some exciting news later this month from JITC's Editor in Chief!

Abstracts of the Breast Cancer Immunotherapy Symposium (BRECIS): Sidra Symposia Series with SITC Now Available

October is a month dedicated to raising breast cancer awareness worldwide. To learn about current initiatives in immunotherapy for breast cancer, download your copy of the Breast Cancer Immunotherapy Symposium (BRECIS): Sidra Symposium Series abstract supplement here.

Understanding Cancer Immunotherapy Patient Resource Guide
Second Edition Now Available

SITC leaders created Understanding Cancer Immunotherapy to provide medically accurate, up-to-date information about immunotherapy. The latest edition features disease-specific content, an expanded clinical trials section, a bladder cancer patient story and a comprehensive immunotherapy timeline.

Download your copy here. To request hard copies to share with your patients and colleagues, visit Patient Resource Publishing.


Latest Career Opportunities from SITC's Job Board

Chief, Melanoma/Soft Tissue Sarcoma
Roswell Park Cancer Institute

Scientist or Associate Scientist
NewLink Genetics – Georgia Regents University Research Institute, Augusta, Georgia

Research Associate
NewLink Genetics – Georgia Regents University Research Institute, Augusta, Georgia

Assistant Professor
Georgia Regents University Cancer Center

Postdoctoral Fellow
Georgia Regents University Cancer Center

View All Job Board Listings

If you are interested in posting an open position to SITC's job board, please reference this agreement form for posting criteria or contact SITC at

Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email:

© 2015 Society for Immunotherapy of Cancer

Join us on:

Twitter  LinkedIn  YouTube  Oncology Tube

If you do not wish to be included in our mailing list, please forward this message to with the word "Remove" in the subject line.

Please add to your safe senders list.